Delivery Order SPE2DB22D2206-SPE2DB25FKB83
- Not listed
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain for the supply of Lidocaine 5% Patch 30s, valued at $14,810.39. This competitively awarded, non-set-aside contract carries a firm fixed price arrangement with an ultimate completion date of July 28, 2025. The product will be delivered to the awardee's facility in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,361.04 by the Defense Logistics Agency (DLA) on August 15, 2025, for the supply of Lidocaine 5% Patch 30s. The contract employs firm fixed-price pricing with a completion deadline of August 18, 2025, and was awarded through open competition with no set-aside designation. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Lidocaine 5% Patch 30s by the Defense Logistics Agency (DLA) on July 21, 2025. This firm fixed-price, competitively awarded contract has a ceiling value of $1,155.74 and an ultimate completion date of July 22, 2025. The award was not designated as a set-aside contract and represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 19, 2025, for the supply of Lidocaine 5% Patch 30s with a ceiling value of $5,131.45. This is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and was competitively awarded without any set-aside designation. The award falls under AmerisourceBergen's existing Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order by the Defense Logistics Agency for Lidocaine 5% Patch 30s on July 8, 2025. The delivery order, valued at $4,520.16, represents a competitive award with no set-aside designation and an ultimate completion date of July 9, 2025. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $3,534.00 for Lidocaine 5% Patch 30S under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The award, issued on September 8, 2025, with an ultimate completion date of the same date, represents a non-set-aside competitive award to support federal medical procurement needs. This delivery order is issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 23, 2025, for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical. The award, valued at $24,464.62, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. The contract is scheduled for ultimate completion on September 24, 2025,...
- The Defense Logistics Agency awarded a delivery order valued at $2,722.08 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Lidocaine 5% Patch 30s, with completion scheduled for September 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,827.45 by the Defense Logistics Agency (DLA) on May 1, 2025, with an ultimate completion date of May 2, 2025. The contract, issued under firm fixed pricing with no set-aside designation, calls for the delivery of Lidocaine 5% Patch in quantities of 30 units to support federal medical procurement needs. This delivery order represents a child...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 7, 2025, for the supply of Lidocaine 5% Patch 30s with a ceiling value of $10,311.22. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is set to be completed by August 8, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKB83Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,277.57 by the Defense Logistics Agency for the supply of Lidocaine 5% Patch 30s. This competitive award, issued on September 24, 2025, with an ultimate completion date of September 25, 2025, represents a firm fixed price contract with no set-aside designation. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for federal military healthcare systems worldwide. The Defense Logistics Agency, operating under the Department of Defense, utilizes the Indefinite Delivery Contract with AmerisourceBergen to procure a broad range of pharmaceutical products and medical supplies for military personnel and veteran healthcare systems. AmerisourceBergen's demonstrated capability to deliver competitively on federal contracts across multiple therapeutic domains, from pain management pharmaceuticals to specialized medical commodities, positions it as a critical vendor in the federal medical supply chain. The company's ability to fulfill orders ranging from modest transactions to substantial procurements underscores its role in supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 9/24/25 |